Current strategies to prevent adult pneumococcal disease have been recently reviewed in Italy. We did a postlicensure study to estimate the direct vaccine effectiveness (VE) of the 13-valent pneumococcal conjugate vaccine (PCV13) against adult pneumococcal community-acquired pneumonia (pCAP).
Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort
Prato, Rosa
;Fortunato, Francesca;Cappelli, Maria Giovanna;Martinelli, Domenico
2018-01-01
Abstract
Current strategies to prevent adult pneumococcal disease have been recently reviewed in Italy. We did a postlicensure study to estimate the direct vaccine effectiveness (VE) of the 13-valent pneumococcal conjugate vaccine (PCV13) against adult pneumococcal community-acquired pneumonia (pCAP).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
e019034.full.pdf
accesso aperto
Tipologia:
PDF Editoriale
Licenza:
Dominio pubblico
Dimensione
960.53 kB
Formato
Adobe PDF
|
960.53 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
